Arterial Spin-Labeling MRI Identifies Abnormal Perfusion Metric at the Gray Matter/CSF Interface in Cerebral Small Vessel Disease

References

1. 1.↵
   1. Mahammedi A,
   2. Wang LL,
   3. Williamson BJ, et al

   . Small vessel disease, a marker of brain health: what the radiologist needs to know. AJNR Am J Neuroradiol 2022;43:650–60 doi:10.3174/ajnr.A7302 pmid:34620594

   Abstract/FREE Full Text
2. 2.↵
   1. Wardlaw JM,
   2. Smith C,
   3. Dichgans M

   . Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013;12:483–97 doi:10.1016/S1474-4422(13)70060-7 pmid:23602162

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Pantoni L

   . Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689–701 doi:10.1016/S1474-4422(10)70104-6 pmid:20610345

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Wardlaw JM,
   2. Smith EE,
   3. Biessels GJ

   ; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1), et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38 doi:10.1016/S1474-4422(13)70124-8 pmid:23867200

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Stewart CR,
   2. Stringer MS,
   3. Shi Y, et al

   . Associations between white matter hyperintensity burden, cerebral blood flow and transit time in small vessel disease: an updated meta-analysis. Front Neurol 2021;12:647848 doi:10.3389/fneur.2021.647848 pmid:34017302

   CrossRefPubMed
6. 6.↵
   1. Han H,
   2. Ning Z,
   3. Yang D, et al

   . Associations between cerebral blood flow and progression of white matter hyperintensity in community-dwelling adults: a longitudinal cohort study. Quant Imaging Med Surg 2022;12:4151–65 doi:10.21037/qims-22-141 pmid:35919044

   CrossRefPubMed
7. 7.↵
   1. Mestre H,
   2. Kostrikov S,
   3. Mehta RI, et al

   . Perivascular spaces, glymphatic dysfunction, and small vessel disease. Clin Sci (Lond) 2017;131:2257–74 doi:10.1042/CS20160381 pmid:28798076

   Abstract/FREE Full Text
8. 8.↵
   1. Shibuya M,
   2. Leite C da C,
   3. Lucato LT

   . Neuroimaging in cerebral small vessel disease: update and new concepts. Dement Neuropsychol 2017;11:336–42 doi:10.1590/1980-57642016dn11-040002 pmid:29354213

   CrossRefPubMed
9. 9.↵
   1. Gouw AA,
   2. Seewann A,
   3. van der Flier WM, et al

   . Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011;82:126–35 doi:10.1136/jnnp.2009.204685 pmid:20935330

   Abstract/FREE Full Text
10. 10.↵
    1. Shi Y,
    2. Thrippleton MJ,
    3. Blair GW, et al

    . Small vessel disease is associated with altered cerebrovascular pulsatility but not resting cerebral blood flow. J Cereb Blood Flow Metab 2020;40:85–99 doi:10.1177/0271678X18803956 pmid:30295558

    CrossRefPubMed
11. 11.↵
    1. Wardlaw JM,
    2. Smith C,
    3. Dichgans M

    . Small vessel disease: mechanisms and clinical implications. Lancet Neurol 2019;18:684–96 doi:10.1016/S1474-4422(19)30079-1 pmid:31097385

    CrossRefPubMed
12. 12.↵
    1. Ter Telgte A,
    2. van Leijsen EMC,
    3. Wiegertjes K, et al

    . Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol 2018;14:387–98 doi:10.1038/s41582-018-0014-y pmid:29802354

    CrossRefPubMed
13. 13.↵
    1. Joseph CR

    . Utilizing 3D arterial spin labeling to identify cerebrovascular leak and glymphatic obstruction in neurodegenerative disease. Diagnostics (Basel) 2021;11:1888 doi:10.3390/diagnostics11101888 pmid:34679586

    CrossRefPubMed
14. 14.↵
    1. Li Y,
    2. Li M,
    3. Zuo L, et al

    . Compromised blood–brain barrier integrity is associated with total magnetic resonance imaging burden of cerebral small vessel disease. Front Neurol 2018;9:221 doi:10.3389/fneur.2018.00221 pmid:29681883

    CrossRefPubMed
15. 15.↵
    1. Petitclerc L,
    2. Hirschler L,
    3. Örzsik B, et al

    . Arterial spin labeling signal in the CSF: implications for partial volume correction and blood–CSF barrier characterization. NMR Biomed 2023;36:e4852 doi:10.1002/nbm.4852 pmid:36269104

    CrossRefPubMed
16. 16.↵
    1. Petitclerc L,
    2. Hirschler L,
    3. Wells JA, et al

    . Ultra-long-TE arterial spin labeling reveals rapid and brain-wide blood-to-CSF water transport in humans. Neuroimage 2021;245:118755 doi:10.1016/j.neuroimage.2021.118755 pmid:34826596

    CrossRefPubMed
17. 17.↵
    1. Aslan S,
    2. Huang H,
    3. Uh J, et al

    . White matter cerebral blood flow is inversely correlated with structural and functional connectivity in the human brain. Neuroimage 2011;56:1145–53 doi:10.1016/j.neuroimage.2011.02.082 pmid:21385618

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Nonaka H,
    2. Akima M,
    3. Hatori T, et al

    . The microvasculature of the cerebral white matter: arteries of the subcortical white matter. J Neuropathol Exp Neurol 2003;62:154–61 doi:10.1093/jnen/62.2.154 pmid:12578225

    CrossRefPubMed
19. 19.↵
    1. Staals J,
    2. Makin SDJ,
    3. Doubal FN, et al

    . Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology 2014;83:1228–34 doi:10.1212/WNL.0000000000000837 pmid:25165388

    CrossRefPubMed
20. 20.↵
    1. Alsop DC,
    2. Detre JA,
    3. Golay X, et al

    . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

    CrossRefPubMed
21. 21.↵
    1. Promjunyakul N,
    2. Lahna D,
    3. Kaye JA, et al

    . Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures. Neuroimage Clin 2015;8:224–29 doi:10.1016/j.nicl.2015.04.012 pmid:26106546

    CrossRefPubMed
22. 22.↵
    1. Debette S,
    2. Schilling S,
    3. Duperron MG, et al

    . Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol 2019;76:81–94 doi:10.1001/jamaneurol.2018.3122 pmid:30422209

    CrossRefPubMed
23. 23.↵
    1. Kapasi A,
    2. DeCarli C,
    3. Schneider JA

    . Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 2017;134:171–86 doi:10.1007/s00401-017-1717-7 pmid:28488154

    CrossRefPubMed
24. 24.↵
    1. Gorelick PB,
    2. Furie KL,
    3. Iadecola C, et al

    . Defining optimal brain health in adults. Stroke 2017;48:e284–303

    Abstract/FREE Full Text
25. 25.↵
    1. Banerjee G,
    2. Jang H,
    3. Kim HJ, et al

    . Total MRI small vessel disease burden correlates with cognitive performance, cortical atrophy, and network measures in a memory clinic population. J Alzheimers Dis 2018;63:1485–97 doi:10.3233/JAD-170943 pmid:29843234

    CrossRefPubMed
26. 26.↵
    1. Charidimou A,
    2. Martinez-Ramirez S,
    3. Reijmer YD, et al

    . Total magnetic resonance imaging burden of small vessel disease in cerebral amyloid angiopathy: an imaging-pathologic study of concept validation. JAMA Neurol 2016;73:994–1001 doi:10.1001/jamaneurol.2016.0832 pmid:27366898

    CrossRefPubMed
27. 27.↵
    1. Fan AP,
    2. Guo J,
    3. Khalighi MM, et al

    . Long-delay arterial spin labeling provides more accurate cerebral blood flow measurements in moyamoya patients: a simultaneous positron emission tomography/MRI study. Stroke 2017;48:2441–49 doi:10.1161/STROKEAHA.117.017773 pmid:28765286

    Abstract/FREE Full Text